| 摘要 |
The invention relates to compounds of formula wherein R is phenyl, unsubstituted or substituted by halogen or -CH<SUB>2</SUB>N(CH<SUB>3</SUB>)(CH<SUB>2</SUB>)<SUB>n</SUB>OCH<SUB>3</SUB>, or is benzyl, lower alkyl, lower alkoxy, -(CH<SUB>2</SUB>)<SUB>n</SUB>OCH<SUB>3</SUB>, or is pyridin 3 -or 4-yl, unsubstituted or substituted by lower alkyl, halogen, morpholinyl, -(CH<SUB>2</SUB>)<SUB>n</SUB>-halogen, -(CH<SUB>2</SUB>)<SUB>n</SUB>OCH<SUB>3</SUB>, -(CH<SUB>2</SUB>)<SUB>n</SUB>-morpholin-4-yl, or -(CH<SUB>2</SUB>)<SUB>n</SUB>-pyrrolidin-1-yl; R<SUP>1 </SUP>is phenyl, unsubstituted or substituted by halogen, tetrahydropyran-4-yl, 3,6-dihydro-2H-pyran-4-yl or morpholin-4-yl; n is independently from each other 1 or 2; and to pharmaceutically acceptable salts thereof for the treatment of diseases related to the adenosine A<SUB>2A</SUB>-receptor.
|
